Pfizer Korea Signs Development Pact With State KRIBB For Liver and Gastric Cancer Drugs

SEOUL - Two years after signing a memorandum of understanding on cooperation, Pfizer and Korea's state-run Korea Research Institute for Bioscience and Biotechnology signed a more formal agreement May 18 to start collaborative research work for joint development of drugs for liver and gastric cancer